Overview
Mohammad Khan is an Oncologist practicing medicine in Sulphur, Louisiana.
Dr. Khan is highly rated in 80 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Paget Disease of the Breast.
He is actively involved in clinical research, co-authoring 1 peer reviewed article.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
619 S Huntington St, Sulphur, LA 70663
109 W 4th St, Deridder, LA 70634
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Office
Leroy Fredericks is an Oncologist practicing medicine in Lake Charles, Louisiana. Dr. Fredericks is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Chronic Lymphocytic Leukemia (CLL), and Small Cell Lung Cancer (SCLC).
Office
Michael Broussard is an Oncologist practicing medicine in Lake Charles, Louisiana. Dr. Broussard is highly rated in 63 conditions, according to our data. His clinical expertise encompasses Hypersplenism, Polycythemia Vera, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.
Golden Triangle Radiation Oncology PLLC
Harry Smith is an Oncologist practicing medicine in Port Arthur, Texas. Dr. Smith is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Breast Cancer, and Desmoplastic Small Round Cell Tumor.
Frequently Asked Questions about Dr. Mohammad Khan
How do I make an appointment with Dr. Mohammad Khan?
You can book an appointment with Dr. Mohammad Khan by calling their office at 337-480-7474. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mohammad Khan a top-rated expert for Thrombocytopenia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mohammad Khan is classified as an Distinguished expert for Thrombocytopenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mohammad Khan specialize in?
While Dr. Mohammad Khan is a Oncology, they have specific expertise in Thrombocytopenia, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Mohammad Khan participate in research or clinical trials?
Yes. Dr. Mohammad Khan has published 1 articles and abstracts on conditions like Thrombocytopenia. You can view a list of Dr. Mohammad Khan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mohammad Khan accept my insurance?
Dr. Mohammad Khan accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 337-480-7474 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AnemiaDr. Khan isDistinguished. Learn about Anemia.
- Breast CancerDr. Khan isDistinguished. Learn about Breast Cancer.
- Drug-Induced ThrombocytopeniaDr. Khan isDistinguished. Learn about Drug-Induced Thrombocytopenia.
- Essential ThrombocythemiaDr. Khan isDistinguished. Learn about Essential Thrombocythemia.
- Hemangioma Thrombocytopenia SyndromeDr. Khan isDistinguished. Learn about Hemangioma Thrombocytopenia Syndrome.
- Iron Deficiency AnemiaDr. Khan isDistinguished. Learn about Iron Deficiency Anemia.
- Advanced
- Acute Eosinophilic PneumoniaDr. Khan isAdvanced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Khan isAdvanced. Learn about Acute Mountain Sickness.
- Adult Soft Tissue SarcomaDr. Khan isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Khan isAdvanced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- Anaplastic Large Cell Lymphoma
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Acute Arterial Occlusion of KidneyDr. Khan isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Lymphoblastic Leukemia (ALL)Dr. Khan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Khan isExperienced. Learn about Acute Myeloid Leukemia (AML).